Market Currents
Valeant Pharmaceuticals (VRX +0.1%) and DepoMed (DEPO +3.0%) sue Watson Pharmaceuticals (WPI...
-
Wednesday, April 18, 2012, 2:56 PM ETValeant Pharmaceuticals (VRX +0.1%) and DepoMed (DEPO +3.0%) sue Watson Pharmaceuticals (WPI +0.2%) over its generic glumetza diabetes drug, according to reports. Sales of Glumetza are tipped to reach more than $100M this year.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
